
Reliance Industries Ltd (RIL) is set to disrupt India’s genomics and diagnostics space
Reliance Industries Ltd (RIL) is set to disrupt India’s genomics and diagnostics space by offering advanced genetic tests at a fraction of prevailing prices—potentially below ₹1,000—a move that could significantly expand access to preventive healthcare. The initiative will be driven…

